XERS
NASDAQ · Pharmaceuticals
Xeris Biopharma Holdings Inc
$6.95
+0.05 (+0.72%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+571.2% upside
Low Target
$35.62
Average Target
$46.65
High Target
$60.75
Current Price
$6.95
Current
$6.95
$6.95
Target
$46.65
$46.65
$35.62
$46.65 avg
$60.75
Scenario Analysis
Bear Case
$35.62
412.5%
Low target
Base Case
$46.65
+571.2%
Avg target
Bull Case
$60.75
+774.1%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$10.08
-31.1% from high
52-Week Low
$4.40
+58.0% from low
Target vs 52W High
$46.65
+362.8% vs high
Peer Consensus — Pharmaceuticals